Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/synaptogenix-announces-new-collaboration-with-lsu-health-new-orleans-for-study-of-proprietary-analogs-in-spinal-cord-injury-302200323.html
https://www.prnewswire.com/news-releases/synaptogenix-announces-fda-authorization-of-ind-application-for-clinical-trial-for-bryostatin-1-in-multiple-sclerosis-302182860.html
https://www.prnewswire.com/news-releases/synaptogenix-applauds-dea-proposal-to-reclassify-cannabis-and-shares-expected-benefits-to-cannasoul-for-cannabinoid-based-drug-discovery-302137968.html
https://www.prnewswire.com/news-releases/synaptogenix-regains-compliance-with-nasdaq-minimum-bid-price-requirement-for-continued-listing-302125770.html
https://www.prnewswire.com/news-releases/synaptogenix-increases-stake-in-innovative-psilocybin-drug-discovery-company-through-its-partnership-with-cannasoul-analytics-302111691.html
https://www.prnewswire.com/news-releases/synaptogenix-announces-reverse-stock-split-to-maintain-nasdaq-listing-302106753.html
https://www.prnewswire.com/news-releases/synaptogenix-president-daniel-l-alkon-md-honored-for-scientific-presentation-at-usc-sponsored-forum-on-age-related-diseases-and-neurodegenerative-disorders-302018822.html
https://www.prnewswire.com/news-releases/synaptogenix-joins-leading-neuroscientists-and-academics-as-speaker-at-usc-sponsored-forum-on-age-related-diseases-including-alzheimers-302007192.html
https://www.prnewswire.com/news-releases/synaptogenix-acquires-significant-stake-in-cannasoul-analtyics-ltd-co-founded-by-the-technion---israel-institute-of-technology-301975492.html
https://www.prnewswire.com/news-releases/synaptogenix-announces-peer-reviewed-publication-of-nih-sponsored-phase-2-clinical-trial-results-demonstrating-safe-significant-and-persistent-benefits-of-bryostatin-1-in-advanced-alzheimers-disease-301938588.html